How to use the speech recognition tool?

NCT04525261

RPE65-NHS

Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene

Type: Observational



Status of the trial: Active, Not recruiting

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2020-05-01
  • Closing Date: 0000-00-00

Criteria

Inclusion: subjects diagnosed with retinitis pigmentosa or Leber congenital amaurosis

Exclusion: participation in a clinical study with an investigational drug during the retrospective study time period (i.e., from 01/01/1990 to study start date)

More information

Children: Yes

Adults: Yes

Funder Type: other


Within ERN-EYE members

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: